Name
Renalpharma OÜ
Registry code
14617678
VAT number
EE102119925
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
30.11.2018 (5)
Financial year
01.01-31.12
Capital
10 000.00 €
Activity
47741 - Retail sale of medical and orthopaedic goods in specialised stores
-
-
-
-
-
-
Not submitted
No tax arrears
-
-
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Vytautas Jucys 15.05.1967 (57) | 60% - 6 000.00 EUR | - | - | Founder |
| Villem Aruoja 13.05.1969 (55) | 40% - 4 000.00 EUR | Board member | Direct ownership | Founder |
| 2019 15.03.2023 | 2020 14.04.2022 | 2021 15.03.2023 | 2022 23.03.2023 | |
|---|---|---|---|---|
| Total Revenue | 1 435 € | 16 418 € | 19 883 € | 56 082 € |
| Net profit (loss) for the period | -2 116 € | 3 393 € | 5 415 € | 18 385 € |
| Profit Margin | -147% | 21% | 27% | 33% |
| Current Assets | 2 859 € | 6 890 € | 24 111 € | 47 818 € |
| Fixed Assets | - | - | - | - |
| Total Assets | 2 859 € | 6 890 € | 24 111 € | 47 818 € |
| Current Liabilities | 2 050 € | 488 € | 9 494 € | 13 816 € |
| Non Current Liabilities | - | - | - | - |
| Total Liabilities | - | - | - | - |
| Share Capital | - | - | - | - |
| Equity | 809 € | 6 402 € | 14 617 € | 34 002 € |
| Employees | 1 | 1 | 1 | 0 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 85 442.87 € | 5 815.17 € | 2 969.68 € | 2 |
| 2023 Q4 | 67 513.33 € | 4 546.05 € | - | 1 |
| 2023 Q3 | 49 742.46 € | 2 245.15 € | - | - |
| 2023 Q2 | 28 816.62 € | 2 253.2 € | - | - |
| 2023 Q1 | 25 341.6 € | 2 983.87 € | - | - |
| 2022 Q4 | 24 819.6 € | 2 891 € | - | 1 |
| 2022 Q3 | 17 935.62 € | 2 030.82 € | - | 1 |
| 2022 Q2 | 25 064.88 € | 2 808.09 € | - | 1 |
| 2022 Q1 | 14 435.97 € | 3 222.65 € | 2 199.59 € | 1 |
| 2021 Q4 | 17 426.5 € | 2 377.86 € | 1 140.89 € | 1 |
| 2021 Q3 | - | - | - | - |
| 2021 Q2 | - | - | - | - |
| 2021 Q1 | - | - | - | - |
| 2020 Q4 | - | - | - | - |
| 2020 Q3 | 20 900.78 € | 0.01 € | - | - |
| 2020 Q2 | 3 637 € | 764.42 € | 845.58 € | - |
| 2020 Q1 | 1 020.36 € | 1 134.39 € | 1 245.05 € | - |
